Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PhRMA Has Labor Support For Extended Biologics Exclusivity

Executive Summary

The Sheet Metal Workers' International Association labor union supports the 12-year data exclusivity for biologics embodied in Sen. Edward Kennedy's follow-on biologics bill

You may also be interested in...

If You Can't Beat 'Em … Hire 'Em? PhRMA Exec Is New GPhA CEO

Chip Davis still believes in innovation, but now must balance that with affordability in new role leading the generic association.

Defense-to-Offense: PhRMA Readies to Protect Government Markets

White House budget targeting biopharma with new cuts hits just as the Pharmaceutical Research & Manufacturers of America’s annual meeting gets under way.

Pfizer Policy Effort Adjusts To Obama Era: Adds Greg Simon, From Obama Transition

Pfizer is aligning its internal policy shop to get more in tune with Democratic Washington. The first major staff change is Greg Simon moving from Faster Cures advocacy group to become senior VP-worldwide policy.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts